Trials / Not Yet Recruiting
Not Yet RecruitingNCT06476223
Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia
Efficacy and Safety of Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hemodialysis patients with xerostomia are divided into 2 groups which are group A (start with artificial saliva containing cumin and ginger extract for 2 weeks, free periods 2 weeks, then placebo for 2 weeks) and group B (start with placebo for 2 weeks, free periods 2 weeks, then artificial saliva containing cumin and ginger extract for 2 weeks). Amount of saliva (g/min), xerostomia's questionnaire, Increase of saliva score, World Health Organization Oral Mucositis Grading Scale, acid and base of saliva, quality of life's questionnaire will measure before, after using the sample for 7 and 14 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Artificial saliva containing cumin and ginger extract | The sample will be sprayed 2 puff/time, 3 times/day, for 14 days. |
| DRUG | Placebo | The sample will be sprayed 2 puff/time, 3 times/day, for 14 days. |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2024-12-30
- Completion
- 2025-01-31
- First posted
- 2024-06-26
- Last updated
- 2024-07-01
Source: ClinicalTrials.gov record NCT06476223. Inclusion in this directory is not an endorsement.